Archives: Agenda

• Reducing development costs through leaner clinical strategies
• Navigating evolving regulatory expectations for biosimilars in Europe and globally
• Understanding how outsourcing models differ for biosimilar programs versus innovative therapies

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

Best 3 LinkedIn posts from day 1 with hashtag #OCT and @Outsourcing in Clinical Trials Event Series tagged will win a prize in day 2 morning’s prize draw during chair’s opening remarks. Deadline end of drinks reception day 1. You must be present to win!

• Defining clear ownership, success metrics, and decision points at every stage of implementation
• Exploring how sponsors, CROs, and technology partners can better align expectations and timelines
• Is the industry too risk-averse to innovate properly?
• Identifying when to pivot, pause, or scale innovations based on measurable impact and long-term feasibility

• Why recruitment forecasts and feasibility assessments across the DACH region continue to miss targets despite strong research infrastructure and healthcare systems
• How increasing study competition, protocol complexity, and limited patient availability are placing growing pressure on sites
• The operational challenges impacting recruitment and patient access across the region
• How sponsors, CROs, and sites can work together to create more realistic feasibility strategies and more sustainable approaches to patient recruitment and site engagement

2 seats available for biotech/ pharma

1 seat available for event sponsor

• Exploring how AI can support end-to-end clinical trial delivery, from protocol authoring and risk assessment through to data analysis and reporting
• Examining how historical trial outcomes, regulatory feedback, and operational data can be leveraged to improve planning, country selection, site strategy, and database design
• Understanding how AI-driven connectivity across departments can break down silos and create a more integrated approach to trial execution
• Discussing how organisations can operationalise AI strategically to future-proof clinical development processes rather than applying disconnected point solutions

1 seat available for event sponsor